Ticker
ENTACompany Name
ENANTA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|
6/30/2025 | $ 162K |
3/31/2025 | $ 190K |
12/31/2024 | $ 241K |
9/30/2024 | $ 147K |
6/30/2024 | $ 79K |
3/31/2024 | $ 251K |
12/31/2023 | $ 1.08M |
9/30/2023 | $ 2.21M |
6/30/2023 | $ 5.14M |
3/31/2023 | $ 9.06M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Minimum
Jun 30, 2024
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 2.9K |
---|---|
min | $ -60.59M |
max | $ 60.64M |
average | $ 124.49K |
median | $ 0 |
std | $ 17.66M |